Table 5.
PUD (n = 22) vs NUD (n = 91) | GC (n = 11) vs NUD (n = 91) | |||||
---|---|---|---|---|---|---|
OR | 95% CI | P value | OR | 95% CI | P value | |
cagA+ vscagA− | 0.42 | 0.16–1.11 | 0.08 | 0.30 | 0.07–1.24 | 0.10 |
cagE+ vscagE− | 0.85 | 0.31–2.30 | 0.74 | 0.27 | 0.05–1.43 | 0.12 |
vacA s1 vs s2 | 1.86 | 0.69–5.01 | 0.22 | 0.55 | 0.10–2.96 | 0.49 |
vacA m1 vs m2 | 1.12 | 0.40–3.20 | 0.83 | 0.58 | 0.15–2.22 | 0.42 |
oipA+ vsoipA− | 0.53 | 0.20–1.41 | 0.20 | 0.10 | 0.01–0.84 | 0.03 |
When calculating the risk for GC vs NUD, ethnic information was not included, as there are no GC cases in other ethnic groups.
cagA+, cagA–positive; cagA−, cagA–negative; cagE+, cagE–positive; cagE−, cagE–negative; oipA+, oipA–positive; oipA−, oipA–negative.
CI, confidence interval; GC, gastric carcinoma; NUD, non-ulcer dyspepsia; OR, odds ratio adjusted by age and sex; PUD, peptic ulcer disease.